We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

614 hedge funds and large institutions have $12.1B invested in Quest Diagnostics in 2017 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 197 increasing their positions, 230 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more call options, than puts

Call options by funds: $18.2M | Put options by funds: $10.1M

47% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 51

7% more capital invested

Capital invested by funds: $11.2B → $12.1B (+$808M)

3% more funds holding

Funds holding: 598 → 614 (+16)

1% more ownership

Funds ownership: 88.35% → 89.35% (+1%)

14% less repeat investments, than reductions

Existing positions increased: 197 | Existing positions reduced: 230

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
614
Holders Change
+16
Holders Change %
+2.68%
% of All Funds
15.29%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
75
Increased
197
Reduced
230
Closed
51
Calls
$18.2M
Puts
$10.1M
Net Calls
+$8.1M
Net Calls Change
-$2.06M

Top Buyers

1
BlackRock
BlackRock
New York
+$1.41B
2
Renaissance Technologies
Renaissance Technologies
New York
+$42.4M
3
JHIU
Janus Henderson Investors US
Colorado
+$32.6M
4
SCP
Seizert Capital Partners
Michigan
+$30.6M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$30.2M

Top Sellers

1
HM
HealthCor Management
New York
-$99.7M
2
Marshall Wace
Marshall Wace
United Kingdom
-$86.8M
3
CIC
Crawford Investment Counsel
Georgia
-$47.5M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$35M
5
Macquarie Group
Macquarie Group
Australia
-$22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
101
Citigroup
New York
$15.5M -$2.44M -25,563 -14%
UBS Group
102
UBS Group
Switzerland
$15.3M +$2M +20,937 +16%
BCIM
103
British Columbia Investment Management
British Columbia, Canada
$14.6M +$7.43M +77,923 +110%
GT
104
Glenmede Trust
Pennsylvania
$14.5M +$87.3K +916 +0.6%
GIA
105
Gateway Investment Advisers
Ohio
$14.3M +$602K +6,316 +5%
WI
106
WBI Investments
New Jersey
$14.3M +$24.5K +257 +0.2%
Barclays
107
Barclays
United Kingdom
$14.3M +$6.3M +66,052 +83%
AP
108
AHL Partners
United Kingdom
$14.1M +$9.63M +101,070 +236%
HA
109
Heartland Advisors
Wisconsin
$14.1M -$3.79M -39,782 -22%
CCM
110
Copeland Capital Management
Pennsylvania
$13.8M -$1.35M -14,193 -9%
Credit Agricole
111
Credit Agricole
France
$13.4M -$2.12M -22,258 -14%
VRS
112
Virginia Retirement Systems
Virginia
$13M +$3.2M +33,600 +34%
DekaBank Deutsche Girozentrale
113
DekaBank Deutsche Girozentrale
Germany
$13M +$4.79M +50,265 +62%
DSA
114
Davis Selected Advisers
Arizona
$12.7M -$7.08M -74,279 -36%
TAM
115
Trillium Asset Management
Massachusetts
$12.7M -$394K -4,134 -3%
VOYA Investment Management
116
VOYA Investment Management
Georgia
$12.5M -$186K -1,954 -2%
National Pension Service
117
National Pension Service
South Korea
$12.2M -$872K -9,151 -7%
BA
118
Boston Advisors
Massachusetts
$12.1M +$4.8M +50,363 +69%
CAM
119
Capstone Asset Management
Texas
$11.7M +$1.03M +10,756 +10%
Chevy Chase Trust
120
Chevy Chase Trust
Maryland
$11.7M +$254K +2,668 +2%
Korea Investment Corp
121
Korea Investment Corp
South Korea
$11.1M +$4.91M +51,469 +83%
IGIM
122
I.G. Investment Management
Manitoba, Canada
$10.9M – – –
JG
123
Jefferies Group
New York
$10.9M +$5.91M +61,973 +127%
PMAM
124
Picton Mahoney Asset Management
Ontario, Canada
$10.7M +$10.4M +109,100 New
DIA
125
Dana Investment Advisors
Wisconsin
$10.5M -$341K -3,574 -3%
3 4
5
6 7

DGX Hedge Fund Activity: Q1 2017 in Review

614 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2017, worth a combined $12.1B — up 7.2% from $11.2B a quarter earlier.

Buyers outnumbered sellers: 75 funds opened new DGX positions and 51 closed out — a net gain of 24 holders — while 197 added to existing stakes and 230 trimmed.

The largest buyer was BlackRock, adding an estimated $1.41B. The largest seller was HealthCor Management, cutting an estimated $99.7M.

  • 614 institutional investors held Quest Diagnostics (DGX) as of Q1 2017, up from 598 in Q4 2016.
  • Funds reported $12.1B of Quest Diagnostics stock for Q1 2017, up 7.2% quarter-over-quarter.
  • 75 funds opened new Quest Diagnostics positions in Q1 2017 and 51 closed out, a net change of +24 holders.
  • The largest Quest Diagnostics buyer in Q1 2017 was BlackRock, an estimated $1.41B added.
  • The largest Quest Diagnostics seller in Q1 2017 was HealthCor Management, an estimated $99.7M sold.

Based on aggregated 13F filings for Q1 2017.